Literature DB >> 15889950

Prospective observational study of treatments for unexplained chronic fatigue.

Suzanne E Bentler1, Arthur J Hartz, Evelyn M Kuhn.   

Abstract

BACKGROUND: Unexplained chronic fatigue is a frequent complaint in primary care. A prospective observational study design was used to evaluate whether certain commonly used therapies for unexplained chronic fatigue may be effective.
METHOD: Subjects with unexplained chronic fatigue of unknown etiology for at least 6 months were recruited from the Wisconsin Chronic Fatigue Syndrome Association, primary care clinics, and community chronic fatigue syndrome presentations. The primary outcome measure was change in a 5-question fatigue score from 6 months to 2 years. Self-reported interventions tested included prescribed medications, non-prescribed supplements and herbs, lifestyle changes, alternative therapies, and psychological support. Linear regression analysis was used to test the association of each therapy with the outcome measure after adjusting for statistically significant prognostic factors.
RESULTS: 155 subjects provided information on fatigue and treatments at baseline and follow-up. Of these subjects, 87% were female and 79% were middle-aged. The median duration of fatigue was 6.7 years. The percentage of users who found a treatment helpful was greatest for coenzyme Q10 (69% of 13 subjects), dehydroepiandrosterone (DHEA) (65% of 17 subjects), and ginseng (56% of 18 subjects). Treatments at 6 months that predicted subsequent fatigue improvement were vitamins (p = .08), vigorous exercise (p = .09), and yoga (p = .002). Magnesium (p = .002) and support groups (p = .06) were strongly associated with fatigue worsening from 6 months to 2 years. Yoga appeared to be most effective for subjects who did not have unclear thinking associated with the fatigue.
CONCLUSION: Certain alternative therapies for unexplained chronic fatigue, especially yoga, deserve testing in randomized controlled trials.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889950     DOI: 10.4088/jcp.v66n0513

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  8 in total

1.  Beneficial effects of a Q-ter based nutritional mixture on functional performance, mitochondrial function, and oxidative stress in rats.

Authors:  Jinze Xu; Arnold Y Seo; Darya A Vorobyeva; Christy S Carter; Stephen D Anton; Angela M S Lezza; Christiaan Leeuwenburgh
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

2.  A preliminary prospective study of nutritional, psychological and combined therapies for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in a private care setting.

Authors:  Megan Anne Arroll; Alex Howard
Journal:  BMJ Open       Date:  2012-11-19       Impact factor: 2.692

3.  The history of ginseng in the management of erectile dysfunction in ancient China (3500-2600 BCE).

Authors:  Rajesh Nair; Senthy Sellaturay; Seshadri Sriprasad
Journal:  Indian J Urol       Date:  2012-01

4.  Azithromycin in chronic fatigue syndrome (CFS), an analysis of clinical data.

Authors:  Ruud C W Vermeulen; Hans R Scholte
Journal:  J Transl Med       Date:  2006-08-15       Impact factor: 5.531

5.  Isometric yoga improves the fatigue and pain of patients with chronic fatigue syndrome who are resistant to conventional therapy: a randomized, controlled trial.

Authors:  Takakazu Oka; Tokusei Tanahashi; Takeharu Chijiwa; Battuvshin Lkhagvasuren; Nobuyuki Sudo; Kae Oka
Journal:  Biopsychosoc Med       Date:  2014-12-11

6.  Ginseng for the Treatment of Chronic Fatigue Syndrome: A Systematic Review of Clinical Studies.

Authors:  Juan Yang; Kyung-Min Shin; Abd Moain Abu Dabrh; Dennis M Bierle; Xuan Zhou; Brent A Bauer; Arya B Mohabbat
Journal:  Glob Adv Health Med       Date:  2022-02-14

7.  Actoprotective effect of ginseng: improving mental and physical performance.

Authors:  Sergiy Oliynyk; Seikwan Oh
Journal:  J Ginseng Res       Date:  2013-04       Impact factor: 6.060

8.  Vascular pharmacology of mokuboito (mu-fang-yi-tang) and its constituents on the smooth muscle and the endothelium in rat aorta.

Authors:  Seiichiro Nishida; Hiroyasu Satoh
Journal:  Evid Based Complement Alternat Med       Date:  2007-09       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.